Skip to content

Understanding the 28 day prescription rule

5 min read

According to the Department of Health, unused medicines cost the National Health Service (NHS) around £300 million every year. To help manage this and improve patient safety, a standard practice known as the 28 day prescription rule has been implemented, limiting the routine supply of repeat medications to this specific interval.

Quick Summary

The 28 day prescription rule sets a standard for dispensing repeat medications, primarily in the UK's NHS, to a 28-day supply. This practice helps to reduce waste, increase safety by minimizing errors, and improve medication management. It also facilitates regular medication reviews by healthcare professionals.

Key Points

  • Origin: The 28-day rule is a UK NHS standard balancing patient convenience, safety, and waste reduction.

  • Primary Purpose: Standardizes repeat prescriptions to a 28-day supply to align dispensing and facilitate regular medication reviews.

  • Key Benefits: Helps reduce medicine waste, minimizes safety risks by preventing over-supply, and enhances medication management for multi-medication patients.

  • Potential Drawbacks: Can increase patient costs (for those who pay) and may lead to more frequent, inconvenient pharmacy visits.

  • Notable Exceptions: Includes medications with fixed pack sizes (HRT, contraceptives), controlled substances with specific regulations, and unstable or new treatments.

In This Article

What is the 28 day prescription rule?

The 28 day prescription rule is a policy, predominantly followed in the United Kingdom, that standardizes the dispensing of repeat medications to a 28-day supply. While not a strict, universally mandated law in all healthcare systems, it is a recognized best practice by many health organizations, including the National Institute for Health and Care Excellence (NICE). The rationale behind this interval balances patient convenience with clinical governance, cost-effectiveness, and patient safety. The rule dictates that patients with long-term conditions should receive enough medication to last for 28 days, ensuring that all their repeat medicines will run out at approximately the same time.

In the United States, a similar, informal “28-day rule” exists but applies specifically to how early a 30-day prescription for a controlled substance can be refilled, typically 1 to 2 days before the 30-day mark. This differs from the UK's broader standard for chronic condition management, as US regulations for prescribing are more complex, involving federal and state laws, as well as insurance policies.

Reasons and benefits of the 28-day cycle

The implementation of a standardized 28-day prescription cycle provides a number of important benefits for both patients and the healthcare system. These advantages primarily revolve around improving safety, reducing waste, and enhancing medication management.

Improved safety through regular reviews

One of the most critical aspects of the 28-day cycle is that it facilitates regular medication reviews. For patients on repeat prescriptions for chronic conditions like diabetes or hypertension, this provides healthcare professionals, including pharmacists and general practitioners, with a consistent opportunity to check on the patient's health. These reviews can identify potential issues such as:

  • Ineffective or inappropriate medication.
  • Adverse side effects.
  • Drug interactions.
  • Changes in the patient's condition that require a different treatment plan.

Reduced medication waste

Significant amounts of medicine are wasted each year, with estimates in the UK reaching into the hundreds of millions of pounds. The 28-day rule helps to minimize this waste in several ways:

  • If a medication is changed or stopped due to side effects or ineffectiveness, only a small quantity remains unused.
  • It discourages the stockpiling of medicines at home, which can lead to confusion and potential mistakes.
  • Patients are more likely to use up their current supply before ordering a new one, preventing the accumulation of unused drugs.

Enhanced medication management

For patients taking multiple medications, a standardized cycle can simplify the process. By synchronizing all repeat prescriptions to the same 28-day schedule, patients can collect all their medicines at once, reducing the number of trips to the pharmacy. This synchronization also makes it easier for healthcare professionals to track adherence and spot any missed prescriptions. Many pharmaceutical companies also produce medicines in 28-day 'calendar packs' to support this daily routine.

Potential drawbacks and challenges

Despite the benefits, the 28-day prescribing policy is not without its critics and presents several challenges for patients.

Increased patient burden and dispensing fees

For patients who pay for their prescriptions, a 28-day cycle can increase their total annual costs, as they will be charged for more prescriptions over the course of a year compared to a longer 90-day supply. Additionally, more frequent visits to the pharmacy for collection or ordering can be inconvenient, especially for individuals with mobility issues or those living in remote areas. For the healthcare system, the cost-effectiveness can be debated; while wastage is reduced, the increased frequency of dispensing and administrative tasks may raise total operational costs.

Adherence issues

Some studies have indicated that longer prescription lengths (e.g., 90-day supplies) can be associated with better medication adherence for patients with stable, long-term conditions. A longer supply removes the need for frequent renewals, reducing the risk of patients running out of medication. Conversely, the frequent nature of the 28-day cycle could be a point of friction that leads to non-adherence for some individuals.

Exceptions to the 28-day rule

Recognizing that a one-size-fits-all approach is not always appropriate, there are several common exceptions to the 28-day rule. These are typically made for specific types of medications or patient situations.

Medications with longer pack sizes

Certain medications, such as some combined oral contraceptives and Hormone Replacement Therapy (HRT), are often manufactured and supplied in larger, multi-month packs. For these items, a longer supply of up to three or six months may be prescribed to align with the manufacturer's packaging and scheduled clinical reviews.

Controlled drugs

Prescriptions for controlled drugs (CDs), particularly those in Schedules 2, 3, and 4 (e.g., opioids and certain sleeping tablets), are strictly limited. In the UK, a supply of no more than 30 days is typically recommended, and these prescriptions have a validity period of 28 days. In the US, refill waiting periods for controlled substances are longer to reduce misuse, but exact rules vary by state and drug schedule.

Acute prescriptions and variable doses

For newly initiated treatments or medications where the dose is still being adjusted, a shorter, acute prescription of 7 or 14 days may be issued to monitor for side effects or effectiveness. Similarly, 'as-required' or variable-dose medications may also be exempt from the standard 28-day cycle.

Comparison of 28-day vs. 90-day prescribing

Feature 28-Day Prescribing 90-Day Prescribing
Waste Reduction Significantly reduces the amount of unused medicine when treatment is changed or stopped. May lead to higher wastage if the medication regimen is altered during the 90-day period.
Patient Adherence Requires more frequent interaction with pharmacies, which can either be beneficial for oversight or inconvenient for some patients. Evidence suggests better adherence for stable patients, as it reduces the frequency of refills.
Safety & Monitoring Facilitates more regular medication reviews and oversight by healthcare professionals. Reduces the frequency of interactions with healthcare providers, which could delay identifying new issues.
Cost (for patients) Can result in higher overall prescription charges due to increased dispensing fees. Typically more cost-effective for patients who pay per item, resulting in fewer total charges per year.
Convenience Requires more frequent pharmacy visits, which can be burdensome for some patients. More convenient for stable patients, as it reduces the number of pharmacy trips.

Conclusion

The 28 day prescription rule represents a deliberate strategy by healthcare systems, particularly the NHS, to balance patient needs with clinical and financial best practices. While it offers substantial benefits in minimizing waste and enhancing patient safety through regular reviews, it also presents challenges related to cost and patient convenience. For stable, long-term patients, alternatives like Electronic Repeat Dispensing (eRD) can mitigate some of these issues by reducing administrative burden. Ultimately, the policy is a flexible guideline, with exceptions made for specific drug types and patient circumstances, ensuring that medication dispensing remains clinically appropriate and safe. Regular communication with pharmacists and general practitioners is essential for patients to understand how the rule applies to their specific care plan.

References

Frequently Asked Questions

In the U.S., the "28-day rule" is an informal term used by some to describe the waiting period for refilling a 30-day supply of a controlled substance, often requiring a wait of at least 28 days between refills. It is not a broad standard for all repeat prescriptions, which are instead governed by federal law, state law, and insurance policies.

A 28-day cycle is often used because it can be divided into a full four weeks, making it easier to synchronize all of a patient's medications to run out at the same time and on the same day of the week. This simplifies medication management and adherence checks for both patients and healthcare providers.

Most pharmacies or healthcare providers will not issue a repeat prescription until the appropriate time. Early refills may be possible in extenuating circumstances, like going on holiday, but typically require prior authorization. For controlled substances, early refills are highly restricted and governed by law.

Electronic Repeat Dispensing (eRD) is an NHS system that allows a prescriber to issue a series of electronic repeat prescriptions for up to 12 months for stable patients. The pharmacy holds these prescriptions, and the patient only needs to visit the pharmacy to collect their 28-day supply at set intervals, reducing the need for constant GP contact.

By dispensing in 28-day intervals, the amount of unused medicine is minimized if a patient's treatment plan changes. This reduces stockpiling and the financial losses associated with unused medication, which can be substantial for national health services.

Yes. In the UK, patients who pay for more than three prescription items in three months or eleven items in twelve months can save money by purchasing a Prescription Pre-Payment Certificate (PPC). There is also a specific PPC for Hormone Replacement Therapy (HRT) items.

Pharmacists are crucial in managing repeat prescriptions under this rule. They dispense the medication, ensure proper adherence to guidelines, conduct medication reviews, and act as a point of contact for patients regarding their medication regimen.

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.